Select Page

EpiVax CEO/CSO Annie De Groot and Director of Analysis Frances Terry co-presented “Engineering Better Biologics: Does Nature Know Best?” at the 2021 AAPS NBC conference May 19th 2021.

Outline: 

 

EpiVax’s discovery of regulatory T cell epitopes (also known as Tregitopes) is very relevant to both biologics and vaccines. EpiVax has developed a suite of tools that can be used to engineer proteins to include or remove T cell epitopes and help researchers design safer and more effective biologics and vaccines.

  • Regulatory T cell epitopes (also known as Tregitopes) is very relevant to both biologics and vaccines.
  • Antibodies naturally have regulatory T cell epitopes while pathogens have been known to introduce Tregitopes into their own sequences as a mechanism of immune escape.
  • EpiVax has developed a suite of tools that can be used to engineer proteins to include or remove T cell epitopes and design safer and more effective biologics and vaccines.